Med Tech Gurus

What if diagnosing coronary artery disease, pulmonary hypertension, and heart failure didn't require a hospital, a specialist, or even invasive testing? In this episode, Adrian Lam , CEO of Corvista Health, shares how their FDA-cleared, AI-powered platform is transforming frontline cardiac care—delivering accurate, non-invasive diagnostics in under 30 minutes. Adrian discusses the delicate balance...

What if a discreet sensor could quietly prevent one of healthcare's most common—and dangerous—IV injuries? In this episode of Med Tech Gurus, Jaclyn Lautz Ph. D., COO of IV Watch, takes us inside the journey of building a global standard of care. Jaclyn shares how her team navigated the EU MDR maze, achieved regulatory approvals across 16 countries, and proved their technology's impact through pow...

What if a simple design shift could save lives in the most chaotic environments? In this episode of Med Tech Gurus, Dr. Irena King, neuroscientist, engineer, and CEO of Surgicure Technologies, shares how she's transforming emergency airway management with the Horseshoe—a novel device born out of battlefield necessity and refined through deep clinical collaboration. Irena reveals the hard lessons o...

What if the key to fixing pharma's toughest challenges wasn't more complexity—but more clarity? In this episode of Med Tech Gurus, Shetal Vyas, SVP of Commercial Strategy & Development at Ardelyx, joins us to explore how digital-first strategies are reshaping how we bring therapies to patients. Shetal unpacks how to overcome the $200 billion patent cliff, reframe customer engagement, and build sca...

What if we could detect Alzheimer's disease before the first memory fades? In this powerful episode of Med Tech Gurus, Dr. Maria-Magdalena Patru, MD, PhD—who leads the neurology medical team at Roche Diagnostics US—explains how early diagnosis is being radically transformed through CSF and blood-based biomarker innovations. With Alzheimer's affecting over 7 million Americans, Dr. Patru outlines ho...

What if the future of clinical trials wasn't just faster—but dramatically more human-centered, efficient, and aligned with real-world outcomes? In this episode of Med Tech Gurus, Meri Beckwith, co-founder of Lindus Health, shares how a broken experience during a COVID trial sparked a revolution in trial design. Lindus is reimagining the traditional CRO with fixed-cost models, milestone-based payme...

What if you could cut your product development time in half—and avoid the regulatory landmines that derail most startups? In this episode of Med Tech Gurus, Marcel Botha, CEO and Founder of 10XBeta, reveals how his Brooklyn-based venture studio helps innovators turn bold ideas into compliant, fundable, and scalable medical technologies. With deep expertise in design, engineering, and regulatory st...

What happens when clinical strategy, bioinformatics, and market access all live under one roof? Meet Tyler O'Malley, VP at Exagen, who shares how this rare triad is driving innovation in autoimmune diagnostics. In this episode, Tyler reveals how real-world data fuels product strategy, why storytelling is key to market access, and how diagnostic innovators can scale in a payer-driven world. We expl...

Behavioral health is in crisis—not just from rising demand, but from the chaos of inconsistent care models, fragmented data, and outdated systems. In this episode of Med Tech Gurus, Jim Szyperski, CEO of Acuity Behavioral Health, shares how his team is bringing much-needed structure and accountability to inpatient psychiatric care.   Backed by a $1.5 million seed round and in collaboration with he...

What if we could finally put real answers behind the brain fog, fatigue, and lingering symptoms so many patients still face post-COVID? In this episode, Dr. Nigel McCracken, Chief Operating Officer at Virax Biolabs, returns to Med Tech Gurus to reveal how their groundbreaking ViraxImmune platform is decoding the hidden dysfunctions of the immune system. With major NHS-led trials underway and U.S....

Billions are being poured into healthcare AI, yet most innovations never make it past pilot projects. Why? And more importantly—how do we fix it? In this episode of Med Tech Gurus , we sit down with Marco Smit, serial entrepreneur, life sciences executive, and AI commercialization expert. With leadership experience at Roche, Genentech, Gesund.ai, CareSyntax, and now Domelabs.ai, Marco has seen the...

What if we could finally crack the code on treating brain cancer by opening the door that's blocked 98% of therapies? In this episode, Dr. Michael Canney, Chief Scientific Officer of Carthera, reveals how SonoCloud—a revolutionary ultrasound implant—temporarily opens the blood-brain barrier to deliver chemotherapy directly to tumors like glioblastoma. With over 100 patients enrolled in a Phase III...

What if the key to solving the provider burnout crisis wasn't adding more hours in the day—but using technology to give them back? In this episode of Med Tech Gurus, we meet David Norris, Co-Founder and CEO of Affinion Health. David shares how his company is building an AI-powered clinical inbox that helps clinicians manage the overwhelming flood of lab results, patient messages, and admin tasks....

What if surgeons could eliminate the guesswork from complex procedures and walk into the OR with a personalized, pre-fitted solution ready to go? In this episode, we meet Vikram Ahuja, Co-Founder and CEO of OsseoLabs, who is transforming orthopedic and maxillofacial surgery using AI and 3D printing. Vikram reveals how his platform builds patient-specific implants using biomechanical data—dramatica...

What turns a brilliant idea into a market-ready medical device? Jennifer Palinchik, CEO of SageMar Medical, has spent over two decades guiding innovators through that exact journey. In this episode, Jennifer shares the critical factors that determine whether your device gets adopted—or ends up on the shelf. From navigating regulatory hurdles and defining market value to aligning R&D with commercia...

Gurus, what if treating prostate cancer no longer required surgery, blood loss, or hospital stays? In this episode, we sit down with Dr. Arun Menawat, CEO of Profound Medical, who is leading a bold transformation in prostate cancer care. With Tulsa Pro—an AI-powered, MRI-guided, incision-free therapy—his team is challenging the surgical status quo head-on. Arun shares how his journey through imagi...

What if your hospital could see , hear , and understand everything happening in the OR—and actually use that data to drive real-time improvements? Dr. Andrew Gostine, CEO and co-founder of Artisight, is making that vision a reality. With AI-powered computer vision and ambient listening, Artisight enables hospitals to automate documentation, reduce delays, and even prevent wrong-site surgeries. Now...

In a world where healthcare demands more from fewer resources, standing still isn't an option. Tim Tinnel, EVP and COO of IntelliGuard, reveals how automation, AI, and intelligent ecosystems are redefining medication management, boosting patient safety, and cutting through operational chaos. We dig into why innovation must be continuous, how true partnerships drive breakthrough solutions, and what...

What if one small valve could change the lives of millions suffering from chronic venous insufficiency? In this episode, we sit down with Rob Berman, CEO of EnVVeno Medical, to explore how his team is disrupting vascular care with the groundbreaking VenoValve—the first surgical solution for deep vein reflux. Rob shares how this innovation is restoring quality of life, slashing wound care costs, an...

Gurus, what if the way we transport life-saving medications like insulin or biologics didn't depend on ice packs, bulky compressors, or outdated infrastructure? What if you could carry a high-performance cold chain system in your backpack—and it held temperature for over 100 hours on a single charge? Meet Faizan Ahmed, CEO of Invensify, the visionary behind Insurg, a solid-state refrigeration tech...

Gurus, what if one of the most overlooked causes of hospital harm—and cost—was also one of the most preventable? Meet Martin Burns, CEO of Bruin Biometrics, a leader in predictive diagnostics aiming to retire outdated wound care models. From the battlefields of hospital-acquired conditions to the boardrooms of investors, Martin is on a mission to reimagine pressure injury prevention through biolog...

Gurus, imagine a future where your voice can flag early signs of Parkinson's or PTSD—where your smartwatch data helps build global research—and where you, not the system, own your health data. That future is already unfolding, and today's guest is helping to build it. Meet Mack Stachowiak, CTO of AxonDAO, a pioneer in blending AI, wearable technology, and decentralized science to revolutionize hea...

Gurus, what happens when a med student asks for a 3D printer for their birthday? For Dhruv Agrawal, Co-Founder and CEO of Aether Biomedical, that gift became the launchpad for a global MedTech breakthrough. In this episode, Dhruv shares how he went from medical school to creating the Zeus Hand—the world's first fully remote-adjustable, repairable, and Medicare-reimbursable bionic hand. With over 8...

Welcome, MedTech Gurus! Imagine cutting weeks off drug manufacturing cycles, reducing compliance headaches, and mining gold from dusty SOPs. That's exactly what today's guest, Reza Farahani, founder of Katalyze AI, is doing. With a unique blend of AI brilliance and biopharma savvy, Reza is helping organizations automate the mundane and accelerate the meaningful. From unlocking insights buried in u...

Welcome, MedTech Gurus! What if the key to reducing ICU infections, saving costs, and restoring patient dignity lay in rethinking something as overlooked as a catheter? In today's episode, Frank Gehres, CEO of Advanced Medical Balloons, shows us how his team is revolutionizing critical care with next-gen balloon technology. From tackling infection-prone ICU environments to pioneering low-pressure,...